Managing homocysteine levels in Parkinson's patients on levodopa
Official title: Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
Run by Oregon Health and Science University · NCT06772220 · Data updated 2026-11-12
This study is testing if giving B vitamins to people with Parkinson's who are taking levodopa can lower their homocysteine levels and improve their thinking skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 90 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Status | Recruiting |
| Started | March 5, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | January 13, 2025 |
| Trial ID | NCT06772220 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40-90 with a diagnosis of probable Parkinson's disease who are currently treated with a minimum of 300 mg/day of levodopa.
✕Probably not a fit
Patients with uncontrolled hypertension or those requiring insulin may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research investigates the levels of homocysteine in patients with Parkinson's disease who are being treated with levodopa. The study aims to determine if B vitamin therapy can effectively lower elevated homocysteine levels and assess the subsequent effects on cognitive function. Participants will receive folic acid, vitamin B6, and vitamin B12 as part of the intervention. The study focuses on understanding the relationship between homocysteine levels and cognitive health in this patient population.
Why it matters
Potential benefit: If successful, this approach could improve cognitive function and overall health in Parkinson's patients receiving levodopa.
How similar studies have gone: While there is limited data on this specific approach, studies addressing homocysteine management in neurological conditions have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of probable Parkinson's Disease according to Movement Disorders Society criteria. 2. Currently treated with levodopa at a minimum dose of 300 mg/day 3. Montreal Cognitive Assessment (MOCA) ≥15 4. Demonstrated capacity to provide informed consent. 5. 40-90 years of age 6. Estimated glomerular filtration rate ≥60 7. Absence of uncontrolled hypertension in medical history 8. Absence of insulin use Exclusion Criteria: \-
Where it's running
-
Oregon Health & Science University (OHSU)
Portland, Oregon, United States Recruiting
Study contacts
- Principal investigator: Joseph Quinn, MD — Oregon Health & Science University (OHSU)
- Study coordinator: Madeline Armendariz Sullivan
- Email: PDResearch@ohsu.edu
- Phone: 503-501-8478
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using deep rTMS to improve memory in Alzheimer's Disease
This study is testing if a new brain treatment called deep rTMS can help improve memory in people with mild to moderate Alzheimer's Disease.
-
Using brain stimulation to improve memory and motivation in older adults
This study is testing if a type of brain stimulation can help improve memory and motivation in older adults, including those showing early signs of Alzheimer's disease.
-
Evaluating outcomes in neurosurgery using standardized measures
This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Home-based brain stimulation plus online chair yoga for chronic knee pain in people with Alzheimer's disease
This project will test whether combining home-based low-intensity brain stimulation (tDCS) with online chair yoga can reduce chronic knee pain in older adults with Alzheimer's disease and related dementias.
-
Carotid artery wall viscosity and memory problems in older adults
This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.